K993771

Substantially Equivalent

CARESIDE DIRECT BILIRUBIN

Applicant: Careside, Inc.
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 1999-11-08
Decision date: 1999-12-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Culver City, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.